Advertisement

Topics

Latest "H3 Pharma Incorporated" News Stories

12:32 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "H3 Pharma Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about H3 Pharma Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about H3 Pharma Incorporated for you to read. Along with our medical data and news we also list H3 Pharma Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of H3 Pharma Incorporated Companies for you to search.

Showing "Pharma Incorporated" News Articles 1–25 of 8,100+

Saturday 23rd March 2019

Bayer-Aktie stürzt Richtung Mehr-Jahres-Tief: Bauernverband pro Glyphosat

Starke Nerven waren gefragt, und nützten am Ende doch wenig. Die Aktie des Leverkusener Pharma- und Agrarchemiekonzerns Bayer stürzte vergangene Woche ab, nachdem ein Gericht in San Francisco zugun...


Friday 22nd March 2019

FDA again issues complete response letter to Recro Pharma for intravenous meloxicam https://firstwordpharma.com/node/1631015?tsid=28®ion_id=6 …

FDA again issues complete response letter to Recro Pharma for intravenous meloxicam https://firstwordpharma.com/node/1631015?tsid=28&region_id=6 …

LG Chem Life Sciences licenses lung cancer vaccine candidate from PDC*line

PDC*line Pharma granted LG Chem Life Sciences Co. exclusive rights to develop and commercialize its PDC*lung lung cancer vacc...


Finance Watch: Flagship Raises $824m To Speed Growth Of Its Portfolio Companies

Private Company Edition: The VC firm and start-up factory Flagship Pioneering brings in new cash for existing investments, tapping into...    

Protein Linked to Cancer Growth Drives Deadly Lung Disease

NewsA protein associated with cancer growth appears to drive the deadly lung disease known as idiopathic pulmonary fibrosis.Contributed A

Up and Down the Ladder: Job Changes.. the latest comings and goings.. recognize anyone? https://www.statnews.com/pharmalot/2019/03/22/ladder-jobs-novartis-mallinckrodt/ … #pharma #jobs $NVS $MNK $ALBO $CORT $VRTX $OVID $AKRX $PRTK $CRNX $PFNX $TYME $C

Up and Down the Ladder: Job Changes.. the latest comings and goings.. recognize anyone? https://www.statnews.com/pharmalot/2019/03/22/ladder-jobs-novartis-mallinckrodt/ … #pharma #jobs $NVS $MNK $ALBO

#news #biotech New computational tool could change how we study pathogens

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New computational tool could change how we study pathogens .A sophisticated new analysis tool developed by Florida State University scientists may signal a new era in the study … Continue reading →

Bayer-Aktie kurz vor Zusammenbruch: Neue Hiobsbotschaft aus den USA

Die Aktie des Leverkusener Pharma- und Agrarchemiekonzerns Bayer findet keinen Halt. Seit der Urteilsverkündung im Verfahren des 70-jährigen Edwin Hardeman hat die Aktie des DAX-Unternehmens über 1...

#news #biotech Conatus and Novartis suffer another midphase NASH flop

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Conatus and Novartis suffer another midphase NASH flop .Conatus Pharmaceuticals’ emricasan has failed another midphase clinical trial. The latest setback saw the Novartis-partnered liver disease drug fail to … Continue reading →

#news #biotech J&J dumps Alios RSV drug, wiping remaining $900M off value

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: J&J dumps Alios RSV drug, wiping remaining $900M off value .Johnson & Johnson has abandoned development of anti-RSV drug AL-8176, wiping another $900 million off the value of … Continue reading →

Alios Buy Best Forgotten For Johnson & Johnson As RSV Failure Costs It Dear

Johnson & Johnson has suspended Phase IIb trial of its RSV asset written off a further $700m against its RSV...   

Adios To Alcon In April As Novartis Confirms Spin-Off Date

With the eye-care business set for its own stock exchange listings next month and the future of Sandoz the subject...    

Novartis confirms Alcon eye care unit spin off next month

Novartis has finalised plans for the long-awaited spin-off of its Alcon eye care business, announcing that the new company will list on April 9. The Swiss pharma has approval for listing on the SIX Swiss Exchange and the New York Stock Exchange, a...

House Democrats Want More Information On Sackler Family’s Role In Opioid Epidemic

The family that found Purdue Pharma has come under intense scrutiny as of late after it was revealed just how deeply involved some of the members were in the early aggressive marketing tactics pursued by the opioid-maker. Meanwhile, an advocacy group is calling on the FDA to impose a moratorium on approving new opioids.

FDA authorises Jazz Pharma's sleep disorder therapy Sunosi http://bit.ly/2TPNYy8  #pharmapic.twitter.com/WykTeKRqoh

FDA authorises Jazz Pharma's sleep disorder therapy Sunosi http://bit.ly/2TPNYy8  #pharma pic.twitter.com/WykTeKRqoh

FDA authorises Jazz Pharma's sleep disorder therapy Sunosi

Jazz Pharmaceuticals has announced that its dopamine and norepinephrine reuptake inhibitor (DNRI) Sunosi (solriamfetol) has been approved by the FDA as a therapy to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnoea (OSA). The authorisation covers doses of 75 mg and 150 mg in narcolepsy and 37.5 mg, 75 mg, and 150 mg in OS...

Pharma fears “lack of focus” on no-deal Brexit preparations

As Brexit is delayed, pharma suggests new measures to avoid no-deal drugs shortages

FDA approves trastuzumab biosimilar Trazimera

Pharma giant Pfizer announced on 11 March 2019 that the US Food and Drug Administration (FDA) had approved its biosimilar version of Roche’s Herceptin (trastuzumab).

Specialists petition #FDA over #opioid approval process http://bit.ly/2U1Cd6V  #opioidepidemic #pharmapic.twitter.com/aAChYKduEY

Specialists petition #FDA over #opioid approval process http://bit.ly/2U1Cd6V  #opioidepidemic #pharma pic.twitter.com/aAChYKduEY

Tate art galleries will not accept donations from Sacklers http://bit.ly/2HMolqE  #OpioidCrisis #pharmapic.twitter.com/2FhfwQg0tb

Tate art galleries will not accept donations from Sacklers http://bit.ly/2HMolqE  #OpioidCrisis #pharma pic.twitter.com/2FhfwQg0tb

Tate art galleries will not accept donations from Sacklers

The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the billionaire controllers of OxyContin drugmaker Purdue Pharma. The decision comes after the National Portrait Gallery turned down a £1 million gift from the Sackler’s who are accused of playing a fundamental role in the opioid epidemic. The backlash follows protests from photographer ...

Bayer-Aktie kämpft mit der letzten Unterstützungslinie

Kulmbach (www.aktiencheck.de) - Bayer-Aktienanalyse von "Der Aktionär": Martin Weiss, stellvertretender Chefredakteur vom Anlegermagazin "Der Aktionär", nimmt die Aktie des Pharma- und Chemiekonzer...

Nasdaq Helsinki Ltd: HERANTIS PHARMA PLC: DIRECTED ISSUE

NOTICE, MARCH 22, 2019 SHARES HERANTIS PHARMA PLC: DIRECTED ISSUE A total of 1,111,982 shares will be traded as old shares as of March 25, 2019. Identifiers of Herantis Pharma Plc's share: Trading ...

J&J bails on RSV drug, taking $900M impairment charge

The big pharma will abandon R&D efforts on its respiratory syncytial virus drug, opening an opportunity for AstraZeneca and Sanofi's experimental candidate.

FDA approves generics from Amneal and Dr Reddy’s, and Natco submits ANDA

In January 2019, the US Food and Drug Administration (FDA) approved Amneal Pharmaceutical’s (Amneal) generic Exelon patch and Dr Reddy’s Laboratories (Dr Reddy’s) Tosymra nasal spray, and Natco Pharma submitted an abbreviated new drug application (ANDA) to FDA for its Ibrutinab tablets.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks